China's healthcare stocks have slumped to their cheapest level ever, as investors abandon defensive sectors for artificial intelligence opportunities. The valuation drop reflects a dramatic shift in capital flows, with money pouring into AI-focused companies while traditional safe-haven sectors lose appeal.

This rotation marks a significant change in market dynamics across Chinese equities. Healthcare stocks, typically viewed as stable investments during uncertain times, now trade at historically low valuations. The trend suggests investors are prioritizing growth potential over defensive positioning.

The capital drain from defensive sectors to AI beneficiaries indicates strong confidence in China's artificial intelligence trajectory. This reallocation could reshape portfolio strategies among institutional investors and fund managers tracking Chinese markets.

The healthcare sector's record-low valuation level represents a clear signal that market sentiment has shifted decisively toward technology-driven growth stories, potentially creating opportunities for contrarian investors.